Skip to main content
OIDA Image Collection
Filters:
Reset 
A timeline of the FDA approval process for a product or service. It is divided into four sections each representing a different stage of the process.<br /><br />The first section is labeled "BE Study FDA Response" and shows the results of the study. The results are:<br /><br />- BE Study FDA Audit Results<br />- Fentanyl 12 FDA Review Restart<br />- FDA Approval<br />- May 2012<br />- June 2012<br /><br />From May 2012 to June 2012 the study was conducted by the FDA. The report was published on June 12 2012 and the report was released on September 9 2012.<br />- Long Lead Time Materials<br />- Risk Occurrence Level<br />- Medium<br />- Low<br />- Pouch Fabrication PV Lots<br />- Remote<br />- Launch<br />- Stability Studies<br /><br />Each stage is represented by a blue line with the first stage on the left side of the timeline and the second stage in the middle. The first stage is marked with a red arrow indicating the launch of the product. The second stage is labeled with a green arrow representing the launch. The third stage is labeled with a blue arrow showing the launch date and the date of the launch and the fourth stage is highlighted with a yellow arrow. The timeline also includes a legend that explains the meaning of each stage and how they interact with each other.

Description Generated using AI

A timeline of the FDA approval process for a product or service. It is divided into four sections each representing a different stage of the process.

The first section is labeled "BE Study FDA Response" and shows the results of the study. The results are:

- BE Study FDA Audit Results
- Fentanyl 12 FDA Review Restart
- FDA Approval
- May 2012
- June 2012

From May 2012 to June 2012 the study was conducted by the FDA. The report was published on June 12 2012 and the report was released on September 9 2012.
- Long Lead Time Materials
- Risk Occurrence Level
- Medium
- Low
- Pouch Fabrication PV Lots
- Remote
- Launch
- Stability Studies

Each stage is represented by a blue line with the first stage on the left side of the timeline and the second stage in the middle. The first stage is marked with a red arrow indicating the launch of the product. The second stage is labeled with a green arrow representing the launch. The third stage is labeled with a blue arrow showing the launch date and the date of the launch and the fourth stage is highlighted with a yellow arrow. The timeline also includes a legend that explains the meaning of each stage and how they interact with each other.

Type

Category

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Cite This Image

Information copied to your clipboard:

"A timeline of the FDA approval process for a product or service. It is divided into four sections each representing a different stage of the process....